Extracranial stereotactic radiotherapy in low and favourable intermediate risk prostate cancer

被引:0
|
作者
Navarro Aznar, V. [1 ]
Mendez Villamon, A. [1 ]
Puertas Valino, M. D. M. [1 ]
Garcia Aguilera, C. [1 ]
Cerrolaza Pascual, M. [1 ]
Lanuza Pascual, A. [1 ]
Ponce Ortega, J. M. [1 ]
Colom, C. [1 ]
Garcia Gimeno, B. [1 ]
Tejedor Gutierrez, M. [1 ]
机构
[1] Miguel Servet Hosp, Radiat Oncol, Zaragoza, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-1499
引用
收藏
页码:S1217 / S1218
页数:2
相关论文
共 50 条
  • [41] STEREOTACTIC BODY RADIOTHERAPY FOR PROSTATE CANCER
    Beltramo, Giancarlo
    Longo, Giovanni
    Locatelli, Cristina
    Bergantin, Achille
    Martinotti, Anna Stefania
    Ria, Francesco
    Invernizzi, Marta
    Vai, Alessandro
    Bianchi, Livia Corinna
    Maggioni, Matteo
    Dormia, Guido
    ANTICANCER RESEARCH, 2015, 35 (06) : 3642 - 3642
  • [42] Stereotactic Body Radiotherapy for Prostate Cancer
    Henderson, D. R.
    Tree, A. C.
    van As, N. J.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 270 - 279
  • [43] Reoxygenation during radiotherapy in intermediate-risk prostate cancer
    Supiot, Stephane
    Rousseau, Caroline
    Dore, Melanie
    Cheze-Le-Rest, Catherine
    Kandel-Aznar, Christine
    Potiron, Vincent
    Guerif, Stephane
    Paris, Francois
    Ferrer, Ludovic
    Campion, Loic
    Meingan, Philippe
    Delpon, Gregory
    Hatt, Mathieu
    Visvikis, Dimitris
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 16 - 19
  • [44] Stereotactic Body Radiotherapy for Prostate Cancer
    Parikh, Neil R.
    Kishan, Amar U.
    AMERICAN JOURNAL OF MENS HEALTH, 2020, 14 (03)
  • [45] Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer
    Bracci, S.
    Osti, M. F.
    Agolli, L.
    Bertaccini, L.
    De Sanctis, V.
    Valeriani, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S641 - S641
  • [46] Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
    Weykamp, Fabian
    Koenig, Laila
    Seidensaal, Katharina
    Forster, Tobias
    Hoegen, Philipp
    Akbaba, Sati
    Mende, Stephan
    Welte, Stefan E.
    Deutsch, Thomas M.
    Schneeweiss, Andreas
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives
    Lo Greco, Maria Chiara
    Marletta, Giulia
    Marano, Giorgia
    Fazio, Alessandro
    Buffettino, Emanuele
    Iudica, Arianna
    Liardo, Rocco Luca Emanuele
    Milazzotto, Roberto
    Foti, Pietro Valerio
    Palmucci, Stefano
    Basile, Antonio
    Marletta, Francesco
    Cuccia, Francesco
    Ferrera, Giuseppe
    Parisi, Silvana
    Pontoriero, Antonio
    Pergolizzi, Stefano
    Spatola, Corrado
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [48] LOW-INTERMEDIATE RISK PROSTATE CANCER TREATED WITH CYBERKNIFE-DELIVERED HYPOFRACTIONATED RADIOTHERAPY
    Scremin, E.
    Tambone, C.
    Bolzicco, G.
    Favretto, M. S.
    D'Amato, G.
    Ferrarese, P.
    Abatangelo, G.
    Nigro, F.
    Tasca, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 52 - 52
  • [49] Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review
    Arcangeli, Stefano
    Scorsetti, Marta
    Alongi, Filippo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 101 - 108
  • [50] The dose response characteristics of low and intermediate risk prostate cancer treated with external beam radiotherapy
    Cheung, R
    Tucker, S
    Lee, A
    de Crevoisier, R
    Dong, L
    Kamat, A
    Pisters, L
    Kuban, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S451 - S452